Delivery Order SPE2DB20D3103-SPE2DB22FM8N6
- Not listed
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,290.33 and is a Firm Fixed Price Delivery Order that runs through August 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,238.27 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of Otezla 30 mg tablets (60s) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The $7,807.93 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $24,369.11, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $17,888.65 and an ultimate completion date of October 17, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov)....
- This federal contract award is for the delivery of Otezla 30 mg tablets in quantities of 60 to the Defense Logistics Agency (DLA). The $35,497.88 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract has an ultimate completion date of January 4, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,842.24 and a completion date of June 9, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is a subsidiary...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order valued at $6,323.01, with a period of performance through January 26, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The $43,466.61 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 15, 2023. AmerisourceBergen is the child company of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $10,291.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4560819661 - Otezla 30 mg tablets. The contract has an ultimate completion date of May 4, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM8N6Delivery Order
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under a Delivery Order valued at $8,213.31. The contract has a completion date of March 3, 2022 and uses a Firm Fixed Price pricing structure. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 3/2/22 |